Why DBS Works for Parkinson’s?

Deep-brain stimulation may effectively treat slow movement, tremor, and rigidity in Parkinson’s patients by reducing synchronicity of neural activity in the motor cortex.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

During surgery to implant a permanent DBS device (green with yellow tip) in the brain of a Parkinson’s patient, six recording electrodes (red) were temporarily placed on the surface of the brain. COURTESY OF CORALIE DE HEMPTINNEStimulate the brain of a patient suffering from Parkinson’s disease (PD) via a surgically implanted electrode and there’s no mistaking the results: the person’s slow movement, tremor, and/or rigidity—common symptoms of the neurodegenerative disorder—all but disappear immediately. When the device is turned off, the motor symptoms return in full force. But how deep-brain stimulation (DBS) effects such changes has been unclear.

In a study published yesterday (April 13) in Nature Neuroscience, researchers at the University of California, San Francisco (UCSF), uncovered evidence to suggest that DBS works by reducing the overly synchronized activity of the motor cortex, which controls the body’s skeletal muscles.

Two years ago, UCSF neurosurgeon Philip Starr, postdoc Coralie de Hemptinne, and their colleagues had identified extremely synchronized neural activity in the cortex as a common factor in the Parkinson’s brain. For the new study, the researchers temporarily placed a strip of six recording electrodes over the motor cortex of 23 Parkinson’s patients during surgery to implant a permanent DBS electrode. Over the course of the six-hour surgery, during which patients are awoken to ensure the proper placement of the DBS electrode, “we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo